Award
NIH Reporter #5U19AI174998-04
mVACS--mRNA Vaccines for C. difficile Suppression
Recipient
University of Pennsylvania, Department of Microbiology/Immunology/Virology
Award Amount
$1,529,954.00
Ceiling
$1,529,954.00
Awarded
May 28, 2026
Identifier
5U19AI174998-04
Funding supports a University of Pennsylvania program developing and evaluating modified mRNA vaccines against C. difficile, including research into vaccine targets, formulations, and immune responses.
Description
The mVACS program aims to design and implement modified mRNA vaccines to mitigate or eliminate Clostridioides difficile infection. It includes vaccine development, antigen discovery, immunology, and administrative, genomics, and clinical cores.